FDA Issues Draft Recommendations for Implementing Decentralized Clinical Trials | Epstein Becker & Green

On May 2, 2023, the U.S. Food and Drug Administration (FDA) took additional steps to support the use of decentralized clinical trials (DCTs) by releasing a new draft guidance titled...

Related Keywords

,Software Used In Conducting Dcts ,Digital Health Technologies ,Drug Administration ,Epstein Becker ,Clinical Trials ,Biological Products ,Drug Omnibus Reform Act ,Dockets Management Staff ,Inferiority Trials ,Clinical Trial Visits ,Clinical Trial Related ,Person Visits ,Trial Related Activities ,Health Technologies ,Remote Data Acquisition ,Clinical Investigations ,